Linker for activation of T cells (LAT) is a scaffolding adaptor protein that is critical for T cell development and function. A mutation of LAT (Y136F) that disrupts phospholipase C-γ1 activation and subsequent calcium influx causes a partial block in T cell development and leads to a severe lymphoproliferative disease in homozygous knock-in mice. One possible contribution to the fatal disease of LAT Y136F knock-in mice could be from autoreactive T cells generated in these mice because of altered thymocyte selection. To examine the impact of the LAT Y136F mutation on thymocyte positive and negative selection, we bred this mutation onto the HY T cell receptor (TCR) transgenic, recombination activating gene-2 knockout background. Female mice with this genotype showed a severe defect in positive selection, whereas male mice exhibited a phenotype resembling positive selection (i.e., development and survival of CD8hi HY TCR-specific T cells) instead of negative selection. These results support the hypothesis that in non-TCR transgenic, LAT Y136F knock-in mice, altered thymocyte selection leads to the survival and proliferation of autoreactive T cells that would otherwise be negatively selected in the thymus.
Skip Nav Destination
Article navigation
4 April 2005
Article|
March 28 2005
Mutation of the phospholipase C-γ1–binding site of LAT affects both positive and negative thymocyte selection
Connie L. Sommers,
Connie L. Sommers
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Search for other works by this author on:
Jan Lee,
Jan Lee
3Division of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892
Search for other works by this author on:
Kevin L. Steiner,
Kevin L. Steiner
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Search for other works by this author on:
Jordan M. Gurson,
Jordan M. Gurson
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Search for other works by this author on:
Corinne L. DePersis,
Corinne L. DePersis
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Search for other works by this author on:
Dalal El-Khoury,
Dalal El-Khoury
2Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Claudette L. Fuller,
Claudette L. Fuller
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Search for other works by this author on:
Elizabeth W. Shores,
Elizabeth W. Shores
3Division of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892
Search for other works by this author on:
Paul E. Love,
Paul E. Love
2Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Lawrence E. Samelson
Lawrence E. Samelson
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Search for other works by this author on:
Connie L. Sommers
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Jan Lee
3Division of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892
Kevin L. Steiner
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Jordan M. Gurson
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Corinne L. DePersis
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Dalal El-Khoury
2Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892
Claudette L. Fuller
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
Elizabeth W. Shores
3Division of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892
Paul E. Love
2Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892
Lawrence E. Samelson
1Laboratory of Cellular and Molecular Biology, National Cancer Institute
CORRESPONDENCE Lawrence E. Samelson: [email protected]
Abbreviations used: DN, double negative; DP, double positive; LAT, linker for activation of T cells; PLC, phospholipase C; SP, single positive.
Received:
October 21 2004
Accepted:
February 03 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
Government
2005
J Exp Med (2005) 201 (7): 1125–1134.
Article history
Received:
October 21 2004
Accepted:
February 03 2005
Citation
Connie L. Sommers, Jan Lee, Kevin L. Steiner, Jordan M. Gurson, Corinne L. DePersis, Dalal El-Khoury, Claudette L. Fuller, Elizabeth W. Shores, Paul E. Love, Lawrence E. Samelson; Mutation of the phospholipase C-γ1–binding site of LAT affects both positive and negative thymocyte selection . J Exp Med 4 April 2005; 201 (7): 1125–1134. doi: https://doi.org/10.1084/jem.20041869
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement